The South African Health Products Regulatory Authority Sahpra has issued a warning that all medicines containing zinc picolinate or selenium and intended for use in children must be withdrawn from the market.
Sahpra chief regulatory officer Tammy Gopal said the regulator had become aware of several products being sold for children that contain zinc picolinate and/or selenium, despite both substances being prohibited in health supplements for minors.
The sale of Category D complementary medicines containing zinc picolinate or selenium and intended for use in children must be withdrawn from the market within six months of the date of this publication, said Gopal.
